News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
FDA has cleared Prime Medicine’s PM359 for the treatment of chronic granulomatous disease
Photo from Prime Medicine/X
May 1, 2024, 12:12

FDA has cleared Prime Medicine’s PM359 for the treatment of chronic granulomatous disease

Prime Medicine shared on X/Twitter:

“We are pleased to announce that FDA has cleared our IND application for PM359 for the treatment of chronic granulomatous disease (CGD), enabling Prime to initiate its Phase 1/2 clinical trial in the US. Details.”

Source: Prime Medicine/X

cancer chronic granulomatous disease clinical trial FDA OncoDaily Oncology PM359 Prime Medicine
Special Coverage
Blog
Mar 31, 2025, 20:43
Akhil Santhosh: Pembrolizumab and lenvatinib show promise in mesothelioma treatment
Blog
Mar 31, 2025, 20:25
A rare glimpse inside doctors’ offices - Moffitt Cancer Center
Blog
Mar 31, 2025, 20:00
2 open positions in the IASLC team
Blog
Mar 31, 2025, 19:08
Predicting response to neoadjuvant chemotherapy in MIBC via interpretable multimodal deep learning
Blog
Mar 31, 2025, 19:01
Colorectal cancer affects all ages: learn your risks - Digestive Cancers Europe
Blog
Mar 31, 2025, 18:51
Insights from GUtrends25 on Urothelial Cancer Treatment by Tom Powles
Blog
Mar 31, 2025, 18:40
Celebrating National Doctors Day - Dolphins Cancer Challenge
Blog
Mar 31, 2025, 18:40
Serre-Beinier Veronique: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 18:35
Binay Shah: Excited to break down barriers and bring quality care to those who need it most
Blog
Mar 31, 2025, 18:27
Bernard A. Fox: UbiVac Seeks Support and Partners to Bring DPV-001 Immunotherapy to Pediatric Cancer Trials
Career
Mar 31, 2025, 18:22
Maryam Yazdy has been appointed as the Senior Medical Director of Clinical Development at BeiGene
Blog
Mar 31, 2025, 18:21
Cecilia Pompili: PROs research from ELCC25 on NSCLC treatment and thoracic surgery